Top Markets
#1 DogBull DogBull +54.65%
#2 Siren Siren +31.05%
#3 OriginTrail OriginTrail +17.89%
#4 Purr Purr +12.64%
#5 Yield Basis Yield Basis +11.36%
#6 龙虾 (Lobster) 龙虾 (Lobster) +10.15%
#7 Stargate Finance Stargate Finance +8.65%
#8 Cysic Cysic +8.61%
#9 COTI COTI +7.71%
#10 MetYa MetYa +7.40%
Coin of the day
DogBull DogBull
Settings
Language
ENGLISH
Currency
USD
Theme
ABIONYX Pharma S.A. ABIONYX Pharma S.A.

ABIONYX Pharma S.A.

ABNX
Rank in Stocks #21916
ABIONYX Pharma SA is a biotechnology company dedicated to the identification... ABIONYX Pharma SA is a biotechnology company dedicated to the identification and advancement of therapies for conditions affecting the kidneys and eyes. The firm's pipeline includes CER-001, an innovative negatively-charged lipoprotein particle. This compound is designed to mimic the structural and functional attributes of pre-beta HDL, utilizing human recombinant apoA-I (a natural high-density lipoprotein protein) along with natural phospholipids like sphingomyelin and dipalmitoylphosphatidylglycerol. CER-001 is currently under development for patients recovering from acute coronary syndrome and those with familial primary hypoalphalipoproteinemia. Another key candidate, CER-002, is a specific agonist for peroxisome proliferator-activated receptor delta, targeting cardiovascular and metabolic diseases. Additionally, CER-209 is being developed as a potential treatment for metabolic liver diseases, atherosclerosis, and non-alcoholic steatohepatitis (NASH). ABIONYX maintains strategic partnerships with GTP Biologics and VBI Therapeutics Group for the bioproduction of its bio-HDL in France. Established in 2005, the company operated as Cerenis Therapeutics Holding SA before its rebranding to ABIONYX Pharma SA in August 2019. Its operations are headquartered in Balma, France.
Share Price
$2.32
Last synced: 2026-08-21
Market Cap
$98.03M
Change (1 day)
-1.91%
Change (1 year)
-5.84%
Country
FR
Trade ABIONYX Pharma S.A. (ABNX)

Category

Healthcare
Stock price history for ABIONYX Pharma S.A. (ABNX)
Highest end of day price: $2.33 on 2026-08-01

Lowest end of day price: $13.49 on 2015-03-01
Stock price history of ABIONYX Pharma S.A. from 2015 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) -8.81%
2025 224.23%
2024 -8.82%
2023 -24.48%
2022 -34.42%
2021 158.51%
2020 191.80%
2019 -43.09%
2018 -69.75%
2017 -74.56%
2016 -34.40%
2015 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $547.71 38.62%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.04K 58.06%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $145.75 437.43%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $118.70 -15.60%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $770.19 8.98%
CH